Spudich, James A. http://orcid.org/0000-0002-4324-4254
Funding for this research was provided by:
National Institute of General Medical Sciences (GM33289)
National Heart, Lung, and Blood Institute (HL117138)
Article History
Received: 20 November 2018
Revised: 11 January 2019
Accepted: 20 January 2019
First Online: 15 February 2019
Compliance with ethical standards
:
: J.A.S. is a cofounder of MyoKardia, a biotechnology company developing small molecules that target the sarcomere for the treatment of inherited cardiomyopathies, and of Cytokinetics and is a member of their scientific advisory boards.